The effect of dexamethasone on the longevity of syringe driver subcutaneous sites in palliative care patients

Medical Journal of Australia

Volumn 178, Issue 10, 2003, Pages 486-489

  Reymond, Liz ^a   Charles, Margaret A ^b   Bowman, Jan ^c   Treston, Pat ^a  

^a Home Care Service   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MATER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; BENZODIAZEPINE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CLONAZEPAM; DEXAMETHASONE; FENTANYL; HALOPERIDOL; HYDROMORPHONE; KETAMINE; METOCLOPRAMIDE; MIDAZOLAM; MORANTEL TARTRATE; MORPHINE SULFATE; OCTREOTIDE; OPIATE DERIVATIVE; PROMETHAZINE; SCOPOLAMINE BUTYL BROMIDE; SODIUM CHLORIDE; SOMATOSTATIN DERIVATIVE; SPASMOLYTIC AGENT; SUFENTANIL;

ABSCESS; ADULT; AGED; ARTICLE; CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG INFUSION; FEMALE; HOSPITAL; HUMAN; INJECTION PAIN; INJECTION SITE; INTESTINE CANCER; LONG TERM CARE; MALE; MOTOR NEURON DISEASE; PALLIATIVE THERAPY; PATIENT CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SOLID TUMOR; SYRINGE; SYSTEMIC THERAPY;

EID: 0038811932     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05321.x     Document Type: Article

References (10)

1. Beswick DT. Use of syringe drivers in terminal care. Pharm J 1987; 238: 656-658.
2. Dover SB. Syringe drivers in terminal care. BMJ 1987; 294: 553-555.
3. Currow D, Cooney N. Comparison of metal versus Vialon subcutaneous catheters in a palliative care setting. Palliat Med 1994; 8: 333-336.
4. Dawkins L, Britton D, Johnson I, et al. A randomized trial of winged Vialon cannulae and metal butterfly needles. Int J Palliat Nurs 2000; 6: 110-116.
5. Ross JR, Saunders Y, Cochrane M, Zeppetella G. A prospective within-patient comparison between metal butterfly needles and Teflon cannulae in subcutaneous infusion of drugs to terminally ill hospice patients. Palliat Med 2002; 16: 13-16.
6. Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: Current practice and problems. Stat Med 2002; 21: 2917-2930.
7. National Health and Medical Research Council. A Guide to the Development, Implementation and Evaluation of Clinical Practice Guidelines. Canberra: NHMRC, 1999.
8. Hardy JR, Rees E, Ling J, et al. A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med 2001; 15: 3-8.
9. O'Doherty CA, Hall EJ, Schofield L, Zeppetella G. Drugs and syringe drivers: A survey of adult specialist palliative care practice in the United Kingdom and Eire. Palliat Med 2001; 15: 149-154.
10. Drummond SH, Peterson GM, Galloway JG, Keefe PA. National survey of drug use in palliative care. Palliat Med 1996; 10: 119-124.